Citadel Advisors »

Traws Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Traws Pharma (TRAW) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Traws Pharma

Tip: Access up to 7 years of quarterly data

All positions including Traws Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Traws Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $28k 25k 1.13

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Traws Pharma

Adage Capital Partners GP
Ikarian Capital
OrbiMed Advisors
Boothbay Fund Management
ADAR1 Capital Management
Vanguard Group
Geode Capital Management
Seven Fleet Capital Management
XTX Topco
State Street Corporation
Citadel Advisors
Two Sigma Investments
Susquehanna International
BlackRock
UBS Group

View all funds holding Traws Pharma